Glatiramir acetate (Copaxone) causes restoration of the striatal dopamine in a progressive MPTP mouse model of Parkinson's disease

被引:0
|
作者
Meshul, C. K.
Churchill, M. J.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
758
引用
收藏
页码:S245 / S246
页数:2
相关论文
共 50 条
  • [1] Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease
    Ilona Joniec-Maciejak
    Adriana Wawer
    Danuta Turzyńska
    Alicja Sobolewska
    Piotr Maciejak
    Janusz Szyndler
    Dagmara Mirowska-Guzel
    Adam Płaźnik
    Pharmacological Reports, 2018, 70 : 988 - 992
  • [2] Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease
    Joniec-Maciejak, Ilona
    Wawer, Adriana
    Turzynska, Danuta
    Sobolewska, Alicja
    Maciejak, Piotr
    Szyndler, Janusz
    Mirowska-Guzel, Dagmara
    Plaznik, Adam
    PHARMACOLOGICAL REPORTS, 2018, 70 (05) : 988 - 992
  • [3] The striatal level of PEP-19 is reduced in the MPTP mouse model of Parkinson's disease
    Svensson, M.
    Skold, K.
    Nilsson, A.
    Caprioli, R.
    Svenningsson, P.
    Andren, P.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S193 - S193
  • [4] Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease
    Zhao, Xin
    Li, Quan
    Zhao, Lei
    Pu, XiaoPing
    PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (12) : 1559 - 1569
  • [5] PYM50028 restores dopamine transporter (DAT) levels in striatal dopamine terminals in a MPTP-lesioned mouse model of Parkinson's disease
    Visanji, N. P.
    Johnston, T. H.
    Brotchie, J. M.
    Hatton, S. L.
    Callizot, N.
    Orsi, A.
    Rees, D.
    MOVEMENT DISORDERS, 2006, 21 : S643 - S643
  • [6] Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson’s disease
    Rainer K. W. Schwarting
    Marco Sedelis
    Katja Hofele
    Georg W. Auburger
    Joseph P. Huston
    Neurotoxicity Research, 1999, 1 : 41 - 56
  • [7] Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease
    Schwarting, Rainer K. W.
    Sedelis, Marco
    Hofele, Katja
    Auburger, Georg W.
    Huston, Joseph P.
    NEUROTOXICITY RESEARCH, 1999, 1 (01) : 41 - 56
  • [8] Protocol for the MPTP mouse model of Parkinson's disease
    Jackson-Lewis, Vernice
    Przedborski, Serge
    NATURE PROTOCOLS, 2007, 2 (01) : 141 - 151
  • [9] Neuroinflammation in the MPTP mouse model and in Parkinson's disease
    Przedborski, S
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 24 - 24
  • [10] Restoration of intestinal function in an MPTP model of Parkinson's Disease
    Ellett, L. J.
    Hung, L. W.
    Munckton, R.
    Sherratt, N. A.
    Culvenor, J.
    Grubman, A.
    Furness, J. B.
    White, A. R.
    Finkelstein, D. I.
    Barnham, K. J.
    Lawson, V. A.
    SCIENTIFIC REPORTS, 2016, 6